Table 3.
Clinical symptoms
| Study | No. stroke patients | Stroke symptoms |
COVID-19 symptoms |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Headache, N (%) | Loss/decreased Consciousness, N (%) | Unilateral hemiparesis/hemiplegia, N (%) | Fever, N (%) | Cough, N (%) | Myalgia, N (%) | Shortness of breath, N (%) | Asymptomatic, N (%) | ||
| Ashrafi et al. | 6 | 6 (100.0) | 4 (66.7) | 3 (50.0) | 4 (66.7) | 3 (50.0) | 0 (0.0) | ||
| Benger et al. | 5 | 3 (60.0) | 2 (40.0) | 3 (60.0) | 5 (100.0) | 3 (60.0) | |||
| Beyrouti et al. | 6 | 4 (66.7) | 1 (16.7) | 2 (33.3) | 1 (16.7) | 2 (33.3) | |||
| Coolen et al. | 19 | 2 (10.5) | 5 (26.3) | 10 (52.6) | 18 (94.7) | ||||
| D'Anna et al. | 8 | 5 (62.5) | 4 (50.0) | 5 (62.5) | |||||
| Escalard et al. | 10 | 5 (50.0) | 3 (30.0) | 2 (20.0) | |||||
| Khan et al. | 22 | 18 (81.8) | 12 (54.5) | 6 (27.3) | |||||
| Kremer et al. | 37 | 4 (10.8) | 27 (73.0) | ||||||
| Mohamud et al. | 6 | 1 (16.7) | 1 (16.7) | 3 (50.0) | 1 (16.7) | 4 (66.7) | 3 (50.0) | 2 (33.3) | |
| Morassi et al. | 6 | 4 (66.7) | 6 (100.0) | 6 (100.0) | |||||
| Oxley et al. | 5 | 1 (20.0) | 4 (80.0) | 5 (100.0) | 1 (20.0) | 2 (40.0) | 2 (40.0) | ||
| Sweid et al. | 22 | 10 (45.5) | 11 (50.0) | 11 (50.0) | 9 (40.9) | ||||
| Overall | 152 | 8 (11.9) | 35 (66.0) | 48 (66.7) | 40 (43.0) | 59 (56.2) | 5 (41.7) | 52 (59.1) | 12 (24.5) |